| Item Type | Name |
|
Concept
|
Survival Rate
|
|
Academic Article
|
Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience.
|
|
Academic Article
|
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
|
|
Academic Article
|
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
|
|
Academic Article
|
Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.
|
|
Academic Article
|
Prognostic indicators in node-negative early stage breast cancer.
|
|
Academic Article
|
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
|
|
Academic Article
|
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
|
|
Academic Article
|
Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
|
|
Academic Article
|
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
|
|
Academic Article
|
Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy.
|
|
Academic Article
|
Sex or survival: trade-offs between quality and quantity of life.
|
|
Academic Article
|
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
|
|
Academic Article
|
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
|
|
Academic Article
|
Is pelvic irradiation necessary in stage III1A Hodgkin's disease?
|
|
Academic Article
|
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
|
|
Academic Article
|
MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients.
|
|
Academic Article
|
Breast conserving surgery and definitive irradiation for early stage breast cancer.
|
|
Academic Article
|
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
|
|
Academic Article
|
Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience.
|
|
Academic Article
|
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment.
|
|
Academic Article
|
Improved survival time trends for glioblastoma using the SEER 17 population-based registries.
|
|
Academic Article
|
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
|
|
Academic Article
|
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.
|
|
Academic Article
|
Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine.
|
|
Academic Article
|
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
|
|
Academic Article
|
Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus.
|
|
Academic Article
|
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs.
|
|
Academic Article
|
The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy.
|
|
Academic Article
|
Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
|
|
Academic Article
|
Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
|
|
Academic Article
|
EPR oxygen images predict tumor control by a 50% tumor control radiation dose.
|
|
Academic Article
|
Effect of postradiotherapy neck dissection on nonregional disease sites.
|
|
Academic Article
|
The oligometastatic state - separating truth from wishful thinking.
|
|
Academic Article
|
Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma.
|
|
Academic Article
|
Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.
|
|
Academic Article
|
Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?
|
|
Academic Article
|
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
|
|
Academic Article
|
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial.
|
|
Academic Article
|
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.
|